THE FINANCIAL — Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé Health Science (NHSc) as a stand-alone business unit called Aimmune Therapeutics, a Nestlé Health Science company, it will manage NHSc‘s global pharmaceutical business. “Nestlé Health Science’s acquisition of Aimmune Therapeutics marks an important milestone in our constant pursuit of innovative, science-based nutritional solutions to support healthier lives,” said Greg Behar, CEO of NHSc. “Aimmune’s PALFORZIA®, the first medication approved for treating peanut allergy, is a game-changer and it’s only the beginning. Aimmune’s pharmaceutical expertise and infrastructure will complement our existing research and development to…
Read More »
THE FINANCIAL — Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé Health Science (NHSc) as a stand-alone business unit called Aimmune Therapeutics, a Nestlé Health Science company, it will manage NHSc‘s global pharmaceutical business. “Nestlé Health Science’s acquisition of Aimmune Therapeutics marks an important milestone in our…
You might be interested in
The FINANCIAL — Over the weekend of the 6th through 7th of August 2022, US senators voted through the night…
High performing managers set harsher targets for their employees, according to new research by Vienna University of Economics and Business.…
The international theater festival named after Nodar Dumbadze was festively completed in Guria. The festival hosted guests in the Ozurgeti…

The FINANCIAL — Société des Produits Nestlé S.A. (“Nestlé”) today announced the results of the tender offer by its wholly-owned subsidiary, SPN MergerSub, Inc. (“Purchaser”), to purchase all of the outstanding shares (“Shares”) of common stock of Aimmune Therapeutics, Inc. (Nasdaq: AIMT) (“Aimmune”), other than any Shares held by Nestlé and its affiliates, for a…
You might be interested in
The FINANCIAL — Over the weekend of the 6th through 7th of August 2022, US senators voted through the night…
High performing managers set harsher targets for their employees, according to new research by Vienna University of Economics and Business.…
The international theater festival named after Nodar Dumbadze was festively completed in Guria. The festival hosted guests in the Ozurgeti…

The FINANCIAL — Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its portfolio of coffee, snacks and water. The Swiss owner of Nespresso will pay $34.50 a share for the U.S. biotech firm, almost triple its last closing price. Aimmune makes a therapy to help reduce allergic…
You might be interested in
The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) and the Presidential Agency for International Cooperation…
Czech Republic, Romania and Croatia has the highest consumption of beer per capita in Eastern Europe
Friday 5th of August is International Beer Day. Did you know that Czech Republic, Romania and Croatia has the highest…
WASHINGTON, D.C. — When Americans are asked to name the most important problem facing the U.S., 8% of the resulting…
by Anam Rizvi — In March, Maira Omer had a summer holiday itinerary for what she described as “half of…